3.3.5. Barriers to deprescribing
Only one of the four studies, a conference abstract, included some
qualitative components in reporting midtrial data. (28) Key barriers
identified from limited clinical data included low levels of clinician
motivation and confidence surrounding how to manage pain with
non-pharmacological techniques, and fear of dealing with aggressive
patients, in particular since the changing of the National Institute for
Health and Care Excellence (NICE) guidelines. (33)